The development of a hypothalamic monoaminergic system for the regulation of the Pars intermedia activity in Xenopus laevis.
D000222:Adaptation, Physiological; D000818:Animals; D002746:Chlorpromazine / Q000494:pharmacology; D002856:Chromatophores / Q000187:drug effects; D003864:Depression, Chemical; D007016:Hypophysectomy; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects / Q000254:growth & development*; D007031:Hypothalamus; D007490:Iproniazid / Q000494:pharmacology; D008543:Melanins / Q000378:metabolism; D009074:Melanocyte-Stimulating Hormones / Q000378:metabolism; D008856:Microscopy, Fluorescence; D008995:Monoamine Oxidase / Q000378:metabolism; D009489:Neurosecretion; D012110:Reserpine / Q000494:pharmacology; D014981:Xenopus / Q000254:growth & development*
D008543:Melanins; D012110:Reserpine; D009074:Melanocyte-Stimulating Hormones; D007490:Iproniazid; D008995:Monoamine Oxidase; D002746:Chlorpromazine